[Multimodal imaging with PET, fMRI and genetic research]

Area of Science:

• Neuroscience
• Medical Imaging
• Genetics

Background:

• Functional magnetic resonance imaging (fMRI) is widely used for brain activation studies, largely replacing older methods.
• Positron emission tomography (PET) and single photon emission computed tomography (SPECT) remain crucial for in vivo assessment of neurotransmitter receptors, transporters, and cerebral blood flow.
• PET and SPECT offer unique capabilities for directly quantifying genotype effects on protein expression.

Purpose of the Study:

• To review current nuclear imaging techniques for quantifying genotype effects on neurotransmitter receptors and transporters.
• To describe multimodal imaging studies combining PET, fMRI, and genetic data.
• To discuss the clinical relevance of these integrated imaging approaches.

Main Methods:

• Review of existing literature on nuclear imaging techniques (PET, SPECT) for genotype-trait associations.
• Description of multimodal imaging studies integrating PET, fMRI, and genetic data.
• Analysis of how genotype or receptor/transporter availability influences functional brain activation.

Main Results:

• PET and SPECT enable direct quantification of genotype effects on neurotransmitter systems.
• Multimodal studies demonstrate the interplay between genotype, neurochemistry, and brain function.
• These approaches provide insights into the biological underpinnings of brain activation.

Conclusions:

• Nuclear imaging, particularly PET and SPECT, is vital for understanding genotype-specific neurobiology.
• Combining nuclear imaging with fMRI and genetics offers a powerful approach to investigate brain function.
• These integrated methods hold significant clinical relevance for personalized medicine and neurological disorders.